Artigos de revistas sobre o tema "Propeptide de la sortiline"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Propeptide de la sortiline".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Hivelin, C., J. Mazella e T. Coppola. "CA-143: Le propeptide de la sortiline module l'entrée de glucose dans les adipocytes et les myocytes". Diabetes & Metabolism 42 (março de 2016): A74. http://dx.doi.org/10.1016/s1262-3636(16)30275-0.
Texto completo da fonteHivelin, Céline, Jean Mazella e Thierry Coppola. "Sortilin derived propeptide regulation during adipocyte differentiation and inflammation". Biochemical and Biophysical Research Communications 482, n.º 1 (janeiro de 2017): 87–92. http://dx.doi.org/10.1016/j.bbrc.2016.10.139.
Texto completo da fontePetersen, C. M. "Propeptide cleavage conditions sortilin/neurotensin receptor-3 for ligand binding". EMBO Journal 18, n.º 3 (1 de fevereiro de 1999): 595–604. http://dx.doi.org/10.1093/emboj/18.3.595.
Texto completo da fonteMazella, J., C. Devader, M. Roulot, M. Borsotto e C. Heurteaux. "Regulation of serum spadin propeptide: An antidepressant response probe". European Psychiatry 33, S1 (março de 2016): S417. http://dx.doi.org/10.1016/j.eurpsy.2016.01.1507.
Texto completo da fonteRoulot, Morgane, Alessandra Minelli, Marco Bortolomasi, Elisabetta Maffioletti, Massimo Gennarelli, Marc Borsotto, Catherine Heurteaux e Jean Mazella. "Increased serum levels of sortilin-derived propeptide after electroconvulsive therapy in treatment-resistant depressed patients". Neuropsychiatric Disease and Treatment Volume 14 (setembro de 2018): 2307–12. http://dx.doi.org/10.2147/ndt.s170165.
Texto completo da fonteDevader, Christelle, Morgane Roulot, Sébastien Moréno, Alessandra Minelli, Marco Bortolomasi, Chiara Congiu, Massimo Gennarelli, Marc Borsotto, Catherine Heurteaux e Jean Mazella. "Serum sortilin-derived propeptides concentrations are decreased in major depressive disorder patients". Journal of Affective Disorders 208 (janeiro de 2017): 443–47. http://dx.doi.org/10.1016/j.jad.2016.10.049.
Texto completo da fonteMazella, Jean, e Jean-Pierre Vincent. "La sortiline : une protéine associée à de multiples fonctions". médecine/sciences 20, n.º 6-7 (junho de 2004): 629–31. http://dx.doi.org/10.1051/medsci/2004206-7629.
Texto completo da fonteKaufman, Beth D., Nancy Videon, Xuemei Zhang, Matthew A. Harris, Robert E. Shaddy e Elizabeth Goldmuntz. "Procollagen type III amino-terminal propeptide: a serum biomarker of left ventricular remodelling in paediatric dilated cardiomyopathy". Cardiology in the Young 25, n.º 2 (6 de novembro de 2013): 228–36. http://dx.doi.org/10.1017/s1047951113001820.
Texto completo da fonteMeiring, S. M., B. D. P. Setlai, C. Theron e R. Bragg. "The Use of Phage Display and Yeast Based Expression System for the Development of a Von Willebrand Factor Propeptide Assay: Development of a Von Willebrand Factor Propeptide Assay". BioMed Research International 2018 (2018): 1–7. http://dx.doi.org/10.1155/2018/6232091.
Texto completo da fonteEmeis, Jef, Henk Bilo, Coen Stehouwer, Claus Thomsen, Ole Rasmussen, Kjeld Hermansen, Claes Wollheim, Jørgen Ingerslev e Ulrich Vischer. "von Willebrand Factor (vWf) as a Plasma Marker of Endothelial Activation in Diabetes: Improved Reliability with Parallel Determination of the vWf Propeptide (vWf:AgII)". Thrombosis and Haemostasis 80, n.º 12 (1998): 1002–7. http://dx.doi.org/10.1055/s-0037-1615401.
Texto completo da fonteBendetowicz, Ana Victoria, Jill A. Morris, Robert J. Wise, Gary E. Gilbert e Randal J. Kaufman. "Binding of Factor VIII to von Willebrand Factor Is Enabled by Cleavage of the von Willebrand Factor Propeptide and Enhanced by Formation of Disulfide-Linked Multimers". Blood 92, n.º 2 (15 de julho de 1998): 529–38. http://dx.doi.org/10.1182/blood.v92.2.529.
Texto completo da fonteBendetowicz, Ana Victoria, Jill A. Morris, Robert J. Wise, Gary E. Gilbert e Randal J. Kaufman. "Binding of Factor VIII to von Willebrand Factor Is Enabled by Cleavage of the von Willebrand Factor Propeptide and Enhanced by Formation of Disulfide-Linked Multimers". Blood 92, n.º 2 (15 de julho de 1998): 529–38. http://dx.doi.org/10.1182/blood.v92.2.529.414k31_529_538.
Texto completo da fonteZHANG, Zhen-Zhong, Satoru NIRASAWA, Yoshiaki NAKAJIMA, Michiteru YOSHIDA e Kiyoshi HAYASHI. "Function of the N-terminal propeptide of an aminopeptidase from Vibrio proteolyticus". Biochemical Journal 350, n.º 3 (8 de setembro de 2000): 671–76. http://dx.doi.org/10.1042/bj3500671.
Texto completo da fonteWit, Thalia Romani de, e Jan van Mourik. "Von Willebrand Factor Propeptide in Vascular Disorders". Thrombosis and Haemostasis 86, n.º 07 (2001): 164–71. http://dx.doi.org/10.1055/s-0037-1616214.
Texto completo da fonteLi, Songtao, Janet L. Smith e Howard Zalkin. "Mutational Analysis of Bacillus subtilisGlutamine Phosphoribosylpyrophosphate Amidotransferase Propeptide Processing". Journal of Bacteriology 181, n.º 5 (1 de março de 1999): 1403–8. http://dx.doi.org/10.1128/jb.181.5.1403-1408.1999.
Texto completo da fonteZhu, Yong, Anush Oganesian, Douglas R. Keene e Linda J. Sandell. "Type IIA Procollagen Containing the Cysteine-rich Amino Propeptide Is Deposited in the Extracellular Matrix of Prechondrogenic Tissue and Binds to TGF-β1 and BMP-2". Journal of Cell Biology 144, n.º 5 (8 de março de 1999): 1069–80. http://dx.doi.org/10.1083/jcb.144.5.1069.
Texto completo da fonteAziz, Mohamed Talaat Abdel, Mohamed Abdel Aziz Wassef, Maha Kamel, Mona El Zein e Hany El Hassan. "Clinical Evaluation of Serum Aminoterminal Propeptide of Type III Procollagen as Tumor Marker in Gynecologic Malignancies". Tumori Journal 79, n.º 3 (junho de 1993): 219–23. http://dx.doi.org/10.1177/030089169307900313.
Texto completo da fonteBoertjes, Ria, Jan van Mourik e Perry van Genderen. "Quantitative Analysis of von Willebrand Factor and Its Propeptide in Plasma in Acquired von Willebrand Syndrome". Thrombosis and Haemostasis 80, n.º 09 (1998): 495–98. http://dx.doi.org/10.1055/s-0037-1615235.
Texto completo da fonteBorchiellini, A., K. Fijnvandraat, JW ten Cate, D. Pajkrt, SJ van Deventer, G. Pasterkamp, F. Meijer-Huizinga, L. Zwart-Huinink, J. Voorberg e JA van Mourik. "Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1- deamino-8-D-arginine vasopressin in humans". Blood 88, n.º 8 (15 de outubro de 1996): 2951–58. http://dx.doi.org/10.1182/blood.v88.8.2951.bloodjournal8882951.
Texto completo da fontevan Mourik, Jan A., Ria Boertjes, Inge A. Huisveld, Karin Fijnvandraat, Dasja Pajkrt, Perry J. J. van Genderen e Rob Fijnheer. "von Willebrand Factor Propeptide in Vascular Disorders: A Tool to Distinguish Between Acute and Chronic Endothelial Cell Perturbation". Blood 94, n.º 1 (1 de julho de 1999): 179–85. http://dx.doi.org/10.1182/blood.v94.1.179.413k18_179_185.
Texto completo da fontePlíhal, O., J. Sklenář, J. Kmoníčková, P. Man, P. Pompach, V. Havlíček, V. Křen e K. Bezouška. "N-glycosylated catalytic unit meets O-glycosylated propeptide: complex protein architecture in a fungal hexosaminidase". Biochemical Society Transactions 32, n.º 5 (26 de outubro de 2004): 764–65. http://dx.doi.org/10.1042/bst0320764.
Texto completo da fonteYeung, P. S. Marie, Nicholas Zagorski e Hélène Marquis. "The Metalloprotease of Listeria monocytogenes Controls Cell Wall Translocation of the Broad-Range Phospholipase C". Journal of Bacteriology 187, n.º 8 (15 de abril de 2005): 2601–8. http://dx.doi.org/10.1128/jb.187.8.2601-2608.2005.
Texto completo da fonteVischer, Ulrich M., Jørgen Ingerslev, Claes B. Wollheim, Jean-Claude Mestries, Dimitrios A. Tsakiris, Walter E. Haefeli e Egbert K. O. Kruithof. "Acute von Willebrand Factor Secretion from the Endothelium In Vivo: Assessment through Plasma Propeptide (vWf:AgII) Levels". Thrombosis and Haemostasis 77, n.º 02 (1997): 387–93. http://dx.doi.org/10.1055/s-0038-1655973.
Texto completo da fonteOda, M. N., S. V. Scott, A. Hefner-Gravink, A. D. Caffarelli e D. J. Klionsky. "Identification of a cytoplasm to vacuole targeting determinant in aminopeptidase I." Journal of Cell Biology 132, n.º 6 (15 de março de 1996): 999–1010. http://dx.doi.org/10.1083/jcb.132.6.999.
Texto completo da fonteMcLeod, R. S., C. Robbins, A. Burns, Z. Yao e P. H. Pritchard. "Deletion of the propeptide of apolipoprotein A-I impairs exit of nascent apolipoprotein A-I from the endoplasmic reticulum". Biochemical Journal 302, n.º 3 (15 de setembro de 1994): 641–48. http://dx.doi.org/10.1042/bj3020641.
Texto completo da fonteLee, SN, E. Prodhomme e I. Lindberg. "Prohormone convertase 1 (PC1) processing and sorting: effect of PC1 propeptide and proSAAS". Journal of Endocrinology 182, n.º 2 (1 de agosto de 2004): 353–64. http://dx.doi.org/10.1677/joe.0.1820353.
Texto completo da fonteBristol, JA, JV Ratcliffe, DA Roth, MA Jacobs, BC Furie e B. Furie. "Biosynthesis of prothrombin: intracellular localization of the vitamin K-dependent carboxylase and the sites of gamma-carboxylation". Blood 88, n.º 7 (1 de outubro de 1996): 2585–93. http://dx.doi.org/10.1182/blood.v88.7.2585.bloodjournal8872585.
Texto completo da fonteHOUBEN, Roger J. T. J., Dayun JIN, Darrel W. STAFFORD, Paul PROOST, Rob H. M. EBBERINK, Cees VERMEER e Berry A. M. SOUTE. "Osteocalcin binds tightly to the γ-glutamylcarboxylase at a site distinct from that of the other known vitamin K-dependent proteins". Biochemical Journal 341, n.º 2 (8 de julho de 1999): 265–69. http://dx.doi.org/10.1042/bj3410265.
Texto completo da fonteGrande, Kerian K., Jean K. Gustin, Efrat Kessler e Dennis E. Ohman. "Identification of Critical Residues in the Propeptide of LasA Protease of Pseudomonas aeruginosa Involved in the Formation of a Stable Mature Protease". Journal of Bacteriology 189, n.º 11 (9 de março de 2007): 3960–68. http://dx.doi.org/10.1128/jb.01828-06.
Texto completo da fontePitkänen, Sari, Matti K. Salo, Kim Vettenranta, Kirsti Näntö‐Salonen e Markku Heikinheimo. "Serum Type III Procollagen in Children with Type I Hereditary Tyrosinemia". Journal of Pediatric Gastroenterology and Nutrition 29, n.º 1 (julho de 1999): 38–41. http://dx.doi.org/10.1002/j.1536-4801.1999.tb02358.x.
Texto completo da fonteOganesian, Anush, Yong Zhu e Linda J. Sandell. "Type IIA Procollagen Amino Propeptide Is Localized in Human Embryonic Tissues". Journal of Histochemistry & Cytochemistry 45, n.º 11 (novembro de 1997): 1469–80. http://dx.doi.org/10.1177/002215549704501104.
Texto completo da fontePulido, Marian, Kenji Saito, Shun-Ichi Tanaka, Yuichi Koga, Masaaki Morikawa, Kazufumi Takano e Shigenori Kanaya. "Ca2+-Dependent Maturation of Subtilisin from a Hyperthermophilic Archaeon, Thermococcus kodakaraensis: the Propeptide Is a Potent Inhibitor of the Mature Domain but Is Not Required for Its Folding". Applied and Environmental Microbiology 72, n.º 6 (junho de 2006): 4154–62. http://dx.doi.org/10.1128/aem.02696-05.
Texto completo da fonteKalafatis, Michael, Daniela Tormene, Sonia Luni, Patrizia Zerbinati, Luisa Barzon, Giorgio Palù, Antonio Girolami e Paolo Simioni. "Abnormal Propeptide Processing Resulting in the Presence of Two Abnormal Species of Protein C in Plasma". Thrombosis and Haemostasis 86, n.º 10 (2001): 1017–22. http://dx.doi.org/10.1055/s-0037-1616527.
Texto completo da fonteFalzon, Liliana, Smita Patel, Yu-Jen Chen e Masayori Inouye. "Autotomic Behavior of the Propeptide in Propeptide-mediated Folding of Prosubtilisin E". Journal of Molecular Biology 366, n.º 2 (fevereiro de 2007): 494–503. http://dx.doi.org/10.1016/j.jmb.2006.11.019.
Texto completo da fonteSteenstrup, Thomas, Claus Kristensen e Gert Bolt. "All post-translational modifications except propeptide cleavage are required for optimal secretion of coagulation factor VII". Thrombosis and Haemostasis 98, n.º 11 (2007): 988–97. http://dx.doi.org/10.1160/th07-05-0332.
Texto completo da fonteJensen, Lars T., Jens O. L. Jørgensen, Juha Risteli, Jens S. Christiansen e Ib Lorenzen. "Type I and III procollagen propeptides in growth hormone-deficient patients: effects of increasing doses of GH". Acta Endocrinologica 124, n.º 3 (março de 1991): 278–82. http://dx.doi.org/10.1530/acta.0.1240278.
Texto completo da fonteLe Loir, Y., S. Nouaille, J. Commissaire, L. Brétigny, A. Gruss e P. Langella. "Signal Peptide and Propeptide Optimization for Heterologous Protein Secretion in Lactococcus lactis". Applied and Environmental Microbiology 67, n.º 9 (1 de setembro de 2001): 4119–27. http://dx.doi.org/10.1128/aem.67.9.4119-4127.2001.
Texto completo da fonteGao, Wenwen, Yaqi Xu, Hongli Liu, Meng Gao, Qing Cao, Yiyi Wang, Longteng Cui et al. "Characterization of missense mutations in the signal peptide and propeptide of FIX in hemophilia B by a cell-based assay". Blood Advances 4, n.º 15 (7 de agosto de 2020): 3659–67. http://dx.doi.org/10.1182/bloodadvances.2020002520.
Texto completo da fonteNiemelä, O., L. Risteli, J. Parkkinen e J. Risteli. "Purification and characterization of the N-terminal propeptide of human type III procollagen". Biochemical Journal 232, n.º 1 (15 de novembro de 1985): 145–50. http://dx.doi.org/10.1042/bj2320145.
Texto completo da fonteNIRASAWA, Satoru, Yoshiaki NAKAJIMA, Zhen-Zhong ZHANG, Michiteru YOSHIDA e Kiyoshi HAYASHI. "Intramolecular chaperone and inhibitor activities of a propeptide from a bacterial zinc aminopeptidase". Biochemical Journal 341, n.º 1 (24 de junho de 1999): 25–31. http://dx.doi.org/10.1042/bj3410025.
Texto completo da fonteDai, Zheng, Heting Fu, Yufeng Zhang, Jing Zeng, Bing Tang e Xiao-Feng Tang. "Insights into the Maturation of Hyperthermophilic Pyrolysin and the Roles of Its N-Terminal Propeptide and Long C-Terminal Extension". Applied and Environmental Microbiology 78, n.º 12 (13 de abril de 2012): 4233–41. http://dx.doi.org/10.1128/aem.00548-12.
Texto completo da fonteO'Neil, Heather S., Brian M. Forster, Kari L. Roberts, Andrew J. Chambers, Alan Pavinski Bitar e Hélène Marquis. "The Propeptide of the Metalloprotease of Listeria monocytogenes Controls Compartmentalization of the Zymogen during Intracellular Infection". Journal of Bacteriology 191, n.º 11 (3 de abril de 2009): 3594–603. http://dx.doi.org/10.1128/jb.01168-08.
Texto completo da fonteGram, Jeppe, Jens Bollerslev, Henning K. Nielsen e Peter Junker. "Increased serum concentrations of type I procollagen C-terminal propeptide and osteocalcin during a short course of calcitriol administration to adult male volunteers". Acta Endocrinologica 125, n.º 6 (dezembro de 1991): 609–13. http://dx.doi.org/10.1530/acta.0.1250609.
Texto completo da fonteHinek, A., A. Reiner e A. R. Poole. "The calcification of cartilage matrix in chondrocyte culture: studies of the C-propeptide of type II collagen (chondrocalcin)." Journal of Cell Biology 104, n.º 5 (1 de maio de 1987): 1435–41. http://dx.doi.org/10.1083/jcb.104.5.1435.
Texto completo da fonteHiggins, G. C., J. L. Foster e A. E. Postlethwaite. "Interleukin 1 beta propeptide is detected intracellularly and extracellularly when human monocytes are stimulated with LPS in vitro." Journal of Experimental Medicine 180, n.º 2 (1 de agosto de 1994): 607–14. http://dx.doi.org/10.1084/jem.180.2.607.
Texto completo da fontePendefunda, Arina Alice Ciocan, Cosmin Gabriel Popa, Daniela Anistoroaei, Ionut Luchian, Gabriela Iftene, Silvia Martu e Norina Consuela Forna. "Quantification of N-Terminal Procollagen I Propeptide in Patients With Occlusal Trauma Induced by Prosthetic Factors". Revista de Chimie 69, n.º 12 (15 de janeiro de 2019): 3556–658. http://dx.doi.org/10.37358/rc.18.12.6813.
Texto completo da fonteOsokina, A. V., V. N. Karetnikova, O. M. Polikutina, IU S. Slepynina, O. V. Gruzdeva, T. P. Artemova, S. N. Ryzhenkova, T. B. Pecherina e O. L. Barbarash. "Procollagen propeptides and visceral obesity index in patients with myocardial infarction with preserved emission faction and various metabolic phenotype". Translational Medicine 7, n.º 1 (11 de março de 2020): 22–32. http://dx.doi.org/10.18705/2311-4495-2020-7-1-22-32.
Texto completo da fonteMaître, Blandine, Catherine Angénieux, Virginie Wurtz, Emilie Layre, Martine Gilleron, Anthony Collmann, Sabrina Mariotti et al. "The assembly of CD1e is controlled by an N-terminal propeptide which is processed in endosomal compartments". Biochemical Journal 419, n.º 3 (14 de abril de 2009): 661–68. http://dx.doi.org/10.1042/bj20082204.
Texto completo da fonteSlepkov, Emily R., Alan Pavinski Bitar e Hélène Marquis. "Differentiation of propeptide residues regulating the compartmentalization, maturation and activity of the broad-range phospholipase C of Listeria monocytogenes". Biochemical Journal 432, n.º 3 (25 de novembro de 2010): 557–66. http://dx.doi.org/10.1042/bj20100557.
Texto completo da fonteWOJCIK, Emiel G. C., Marieke VAN DEN BERG, Swibertus R. POORT e Rogier M. BERTINA. "Modification of the N-terminus of human factor IX by defective propeptide cleavage or acetylation results in a destabilized calcium-induced conformation: effects on phospholipid binding and activation by factor XIa". Biochemical Journal 323, n.º 3 (1 de maio de 1997): 629–36. http://dx.doi.org/10.1042/bj3230629.
Texto completo da fonte